People · Operator

Nathan Arieh Every

Named in public records as an officer, director or promoter · active 2010–2014 · Other Health Care

1
Companies
7
Filings
$146.8M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
PowerVision, Inc.Other Health CareSeries C$146.8M$1.0B2010
Operator network

Nathan Arieh Every at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Barry Cheskin · 2 companies · 1 sharedBarry CheskinBrian Flaherty · 2 companies · 1 sharedBrian FlahertyBryan Arieh Roberts · 1 companies · 1 sharedBryan Arieh Rober…Damion Arieh Wicker · 1 companies · 1 sharedDamion Arieh Wick…Drew Arieh Schiff · 1 companies · 1 sharedDrew Arieh SchiffGeorge Arieh Green · 1 companies · 1 sharedGeorge Arieh GreenHenry Arieh Wu · 1 companies · 1 sharedHenry Arieh WuJames Arieh McCollum · 1 companies · 1 sharedJames Arieh McCol…Lou Arieh Bock · 1 companies · 1 sharedLou Arieh BockMatthew Frinzi · 1 companies · 1 sharedMatthew FrinziMichael Arieh Carusi · 1 companies · 1 sharedMichael Arieh Car…Renee Arieh Ryan · 1 companies · 1 sharedRenee Arieh RyanS. Arieh Zak · 1 companies · 1 sharedS. Arieh ZakPowerVision, Inc. · $146.8M raisedPowerVision, Inc.Nathan Arieh EveryNE
Nathan Arieh Every Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Nathan Arieh Every on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Brian Flaherty12
Barry Cheskin12
Bryan Arieh Roberts11
Matthew Frinzi11
James Arieh McCollum11
S. Arieh Zak11
Damion Arieh Wicker11
Drew Arieh Schiff11
Lou Arieh Bock11
George Arieh Green11
Renee Arieh Ryan11
Henry Arieh Wu11
Michael Arieh Carusi11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.